The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Risk factors for clostridium difficile infection in children with malignancy.
P. M. K. De Blank
No relevant relationships to disclose
T. Zaoutis
Consultant or Advisory Role - Merck; Pfizer
Honoraria - Merck
Research Funding - Merck
Expert Testimony - Comerford and Britt; Goodell, Devries LLP; Greensfelder, Henker and Gale, LLP; Rosensweig, Esq
B. Fisher
Research Funding - Pfizer
A. B. Troxel
No relevant relationships to disclose
J. Kim
Consultant or Advisory Role - Optima Group Pharma
Research Funding - ViroPharma
R. Aplenc
No relevant relationships to disclose